ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,835Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 98

$1.52M Total Retail Price of All Prescriptions

Rank: 6 out of 98

776 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 776 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

6% of this provider’s 776 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 27,189 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,596 1,553 1 1
SIMVASTATIN 1,418 1,288 2 2
FUROSEMIDE 1,125 1,078 3 4
LEVOTHYROXINE SODIUM 957 886 4 5
LISINOPRIL 890 813 5 3
METOPROLOL TARTRATE 848 810 6 8
TRAZODONE HCL 800 745 7 9
OMEPRAZOLE 760 672 8 6
CITALOPRAM HBR 719 666 9 10
ATENOLOL 715 682 10 14
AMLODIPINE BESYLATE 609 577 11 7
METFORMIN HCL 552 493 12 15
GABAPENTIN 538 461 13 13
POTASSIUM CHLORIDE 535 497 14 21
DONEPEZIL HCL 526 526 15 12
MIRTAZAPINE 507 492 16 11
NAMENDA 415 415 17 18
HYDROCHLOROTHIAZIDE 362 316 18 17
SERTRALINE HCL 293 286 19 19
TRAMADOL HCL 282 268 20 26
POLYETHYLENE GLYCOL 3350 278 261 21 33
ATORVASTATIN CALCIUM 277 256 22 20
ADVAIR DISKUS 275 261 23 32
PRAVASTATIN SODIUM 257 213 24 41
METOPROLOL SUCCINATE 256 237 25 16
DIVALPROEX SODIUM 234 184 26 22
LIDODERM 218 203 27 29
RISPERIDONE 211 178 28 27
LOSARTAN POTASSIUM 200 172 29 34
CLOPIDOGREL 200 172 29 50
ALLOPURINOL 199 195 31 43
LOVASTATIN 178 178 32 81
TAMSULOSIN HCL 178 164 32 25
PANTOPRAZOLE SODIUM 177 176 34 42
DIGOXIN 173 169 35 40
SPIRIVA 173 162 35 46
CYMBALTA 169 151 37 47
ISOSORBIDE MONONITRATE ER 168 161 38 36
HYDROCODONE-ACETAMINOPHEN 167 159 S3 39 39
PREDNISONE 165 162 40 31
KLOR-CON M20 163 163 41 69
BACLOFEN 157 117 42 59
LEVEMIR 153 130 43 110
PROAIR HFA 146 113 44 58
GLYBURIDE 145 142 R 45 70
QUETIAPINE FUMARATE 142 106 46 23
LANTUS 141 116 47 28
RANITIDINE HCL 141 122 47 35
CARBIDOPA-LEVODOPA 140 101 49 44
PLAVIX 139 123 50 76
HYDRALAZINE HCL 138 134 51 75
IPRATROPIUM-ALBUTEROL 131 129 52 45
NYSTATIN 131 130 52 56
OLANZAPINE 129 127 54 24
ALENDRONATE SODIUM 119 112 55 30
ZETIA 119 104 55 144
FAMOTIDINE 118 118 57 80
FLUOXETINE HCL 118 98 57 48
CLOZAPINE 117 117 59 55
GLIPIZIDE 112 108 60 37
DILTIAZEM 24HR CD 112 99 60 83
BUPROPION HCL SR 111 90 62 100
CARVEDILOL 103 97 63 72
NOVOLOG 102 95 64 54
ZOLPIDEM TARTRATE 101 73 65 90
JANUVIA 100 100 66 120
DICLOFENAC SODIUM 99 87 67 178
IBUPROFEN 97 75 68 74
BUPROPION HCL 97 96 68 96
FLUTICASONE PROPIONATE 97 97 68 53
VENLAFAXINE HCL 97 89 68 116
BRIMONIDINE TARTRATE 97 97 68 95
FINASTERIDE 97 97 68 49
SPIRONOLACTONE 96 66 74 71
AZITHROMYCIN 95 86 75 104
LATANOPROST 94 94 76 67
PAROXETINE HCL 92 92 77 73
VERAPAMIL ER 92 92 77 175
LEVOFLOXACIN 85 81 79 63
PHENYTOIN SODIUM EXTENDED 81 61 80 101
ABILIFY 81 71 80 66
MECLIZINE HCL 79 55 82 164
ROPINIROLE HCL 77 51 83 91
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 73 84 114
NOVOLIN R 74 59 85 79
OXYBUTYNIN CHLORIDE ER 73 61 86 88
SYMBICORT 70 70 87 187
NIFEDIPINE ER 69 62 88 68
FLOVENT HFA 69 59 88 135
LEVETIRACETAM 68 47 90 38
HYDROXYCHLOROQUINE SULFATE 67 61 91 265
KLOR-CON M10 65 65 92 176
VENLAFAXINE HCL ER 64 60 93 65
CEPHALEXIN 63 60 94 92
SEROQUEL 63 44 94 52
ESCITALOPRAM OXALATE 63 53 94 60
SINGULAIR 61 53 97 117
NEXIUM 60 57 98 161
ERYTHROMYCIN 59 58 99 107
GEMFIBROZIL 58 55 100 125
KLOR-CON 10 57 57 101 277
TERAZOSIN HCL 57 51 101 94
LAMOTRIGINE 56 51 103 87
LOPERAMIDE 55 54 104 190
GENERLAC 54 23 105 82
AMOX TR-POTASSIUM CLAVULANATE 53 49 106 194
CLOTRIMAZOLE-BETAMETHASONE 53 45 106 115
NYSTOP 52 52 108 64
DIOVAN 52 52 108 57
CRESTOR 51 51 110 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.